U.S. market Closed. Opens in 11 hours 20 minutes

COLL | Collegium Pharmaceutical, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for COLL we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is moderate, Growth is on medium level and Health is weak.

Valuation (72%)

Company Industry
P/E Ratio (TTM) 12.18 24.50
PEG Ratio (TTM) 0.58 2.33
P/S Ratio (TTM) 2.09 5.42
P/B Ratio (TTM) 5.62 5.06
P/FCF Ratio (TTM) 4.38 11.26
Price to 5YR AVG Earnings Ratio 57.36 5.17
Price to 5YR AVG FCF Ratio 11.23 23.99

Profitability (55%)

Company Industry
ROA (TTM) 9.48% 3.20%
ROE (TTM) 49.14% 31.38%
Net Profit Margin (TTM) 17.32% -10.10%
ROIC 5YR AVG -0.65% 10.85%

Growth (60%)

4QTR AVG 3YR AVG 5YR AVG
EPS 19.86% 222.55% 164.96%
Revenue 1.85% -0.13% 17.87%
Net Income 17.74% 224.95% 166.50%
Cash Flow -8.36% -66.67% -15.77%

Health (44%)

Company Industry
Current Ratio (TTM) 1.11 2.49
Quick Ratio (TTM) 1.04 1.83
D/E Ratio (TTM) 2.56 -0.01
Interest Coverage (TTM) 2.79 12.09
Piotroski F-Score 8 6
Altman Z-Score 1.89 4.74
LTL to 5YR AVG FCF 4.55 4.47
Shares Outstanding Growth 5YR AVG 0.50% 28.76%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙